Status:
COMPLETED
Left Atrial Appendage Occlusion Guided by 3D Printing
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Hôpital Privé Les Franciscaines
Henri Mondor University Hospital
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Left atrial appendage closure (LAAC) was approved by the ESC guidelines as a stroke prevention alternative to warfarin for patients with nonvalvular atrial fibrillation in patients at high risk of ble...
Detailed Description
The 3D printing has modified the LAAC practices with a preoperative time allowing an optimal preparation of the prosthesis. This technique is now used in several surgical centers and prospective evalu...
Eligibility Criteria
Inclusion
- non valvular AF
- adressed for LAAC procedure
Exclusion
- opposition from patients
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03330210
Start Date
December 1 2017
End Date
December 1 2019
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Privé les Franciscaines
Nîmes, France, 30032